by In2Pharma | Feb 14, 2014 | News, Newsletter
After the 2013 breast implant scandal in France , the Belgian medical device industry was a great advocate to implement an overall quality system for implantable medical devices to ensure the quality and safety. After a joint approach of the Belgian government and the...
by In2Pharma | Feb 10, 2014 | News, Newsletter
Marketing authorization holders of authorized medicines for human/veterinary use are no longer obliged to inform both the Federal Agency for Medicines and Health Products (FAMHP) and the National Institute for Health and Disability Insurance (NIHDI) of any changes in...
